Abstract
14Apr 2020 RESULTS OF ADJUVANT PACLITAXEL AND CARBOPLATIN AFTER CONCURRENT CHEMO RADIATION (CCRT) IN LOCALLY ADVANCED CERVICAL CANCER (LACC) B.K. Shewalkar , Punita Pant , Jitendra Patel , Roopa B. and H. Khadilkar Professor & Head, Department of Radiotherapy and Oncology, Department of P.S.M, Government Medical College and Cancer Hospital Aurangabad, Maharashtra. Associate Professor, Department of Radiotherapy and Oncology, Department of P.S.M, Government Medical College and Cancer Hospital Aurangabad, Maharashtra. Resident, Department of Radiotherapy and Oncology, Department of P.S.M, Government Medical College and Cancer Hospital Aurangabad, Maharashtra.
Highlights
Concurrent chemo radiation (CCRT) is the standard treatment for locally advanced cervical cancer (LACC) Federation of Gynaecology and Obstetrics (FIGO) stage IIB-IVA.failure rate after treatment is still as high as 30% to 40% of which local and distant failures are 17% and 18% respectively Key words:-Chemoradiation, Chemotherapy,Cervical Carcinoma, Paclitaxel, Carboplatin and the 5-year survival is still poor.Aim of incorporating adjuvant chemotherapy (ACT) is to target the residual disease in the pelvis and to treat occult disease outside the pelvis
This study aims to evaluate the feasibility and benefit of adjuvant chemotherapy (ACT) after CCRT in such patients to the improve treatment outcome
All patients received radiation upto 50Gy with Cisplatin 40 mg/ m2 followed by intra-cavitary radiotherapy- 3fractions of 7 Gy each (28 Gy equivalent)
Summary
OF ADJUVANT PACLITAXEL AND CARBOPLATIN AFTER CONCURRENT CHEMO RADIATION (CCRT) IN LOCALLY ADVANCED CERVICAL CANCER (LACC). Dr B.K. Shewalkar, Dr Punita Pant, Dr Jitendra Patel, Dr Roopa B.3 and Dr H. 1. Professor & Head, Department of Radiotherapy and Oncology, Government Medical College and Cancer. 2. Associate Professor, Department of Radiotherapy and Oncology, Department of P.S.M, Government. Medical College and Cancer Hospital Aurangabad, Maharashtra. 3. Resident, Department of Radiotherapy and Oncology, Government Medical College and Cancer Hospital
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.